DE69631290D1 - Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren - Google Patents

Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren

Info

Publication number
DE69631290D1
DE69631290D1 DE69631290T DE69631290T DE69631290D1 DE 69631290 D1 DE69631290 D1 DE 69631290D1 DE 69631290 T DE69631290 T DE 69631290T DE 69631290 T DE69631290 T DE 69631290T DE 69631290 D1 DE69631290 D1 DE 69631290D1
Authority
DE
Germany
Prior art keywords
microspheres
biodegradable
peptide
prepared
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69631290T
Other languages
English (en)
Inventor
Younsik Cha
Young Kweon Choi
Min Pai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MacroMed Inc
Original Assignee
MacroMed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MacroMed Inc filed Critical MacroMed Inc
Application granted granted Critical
Publication of DE69631290D1 publication Critical patent/DE69631290D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D7/00—Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
DE69631290T 1995-10-25 1996-10-25 Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren Expired - Lifetime DE69631290D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/547,962 US5665428A (en) 1995-10-25 1995-10-25 Preparation of peptide containing biodegradable microspheres by melt process
PCT/US1996/017237 WO1997015389A1 (en) 1995-10-25 1996-10-25 Preparation of peptide containing biodegradable microspheres by melt process

Publications (1)

Publication Number Publication Date
DE69631290D1 true DE69631290D1 (de) 2004-02-12

Family

ID=24186865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631290T Expired - Lifetime DE69631290D1 (de) 1995-10-25 1996-10-25 Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren

Country Status (9)

Country Link
US (1) US5665428A (de)
EP (1) EP0857081B1 (de)
JP (1) JPH11515016A (de)
KR (1) KR100422391B1 (de)
AT (1) ATE257407T1 (de)
AU (1) AU7479796A (de)
CA (1) CA2235602A1 (de)
DE (1) DE69631290D1 (de)
WO (1) WO1997015389A1 (de)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
IL110787A0 (en) 1993-08-27 1994-11-11 Sandoz Ag Biodegradable polymer, its preparation and pharmaceutical composition containing it
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
DE19715504C2 (de) * 1997-04-14 2000-10-26 Max Planck Gesellschaft PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen
US6342250B1 (en) 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
PT1034207E (pt) * 1997-10-03 2005-07-29 Macromed Inc Copolimeros tribloco de poli(lactido-co-glicolido) e polietilenoglicol, de baixo peso molecular, biodegradaveis, com propriedades de gelificacao termica inversa
US6201072B1 (en) * 1997-10-03 2001-03-13 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
ZA9811379B (en) * 1997-12-12 1999-08-27 Macromed Inc Hetero-functionalized star-shaped poly(ethylene glycols) for protein modification.
EP1049458B1 (de) * 1998-01-21 2003-03-26 Takeda Chemical Industries, Ltd. Verfahren zur gerfriertrocknung von präparaten mit verzörgerter wirkstoffabgabe
GB9808052D0 (en) 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
CN1207090C (zh) * 1998-04-27 2005-06-22 陶氏化学公司 包囊化活性材料
US20050147690A1 (en) * 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US20030007991A1 (en) * 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US7662409B2 (en) * 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
KR100274842B1 (ko) * 1998-10-01 2001-03-02 김효근 미립구를 이용한 레티노익산의 서방형 약물방출 시스템
GB9905136D0 (en) * 1999-03-06 1999-04-28 Danbiosyst Uk Surface modification of lamellar particles
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
EP1185312B1 (de) * 1999-05-27 2005-03-23 Monsanto Company Biomaterialien, modifiziert mit superoxid-dismutase imitatoren
US20040110722A1 (en) * 1999-05-27 2004-06-10 Ornberg Richard L. Modified hyaluronic acid polymers
US6521431B1 (en) * 1999-06-22 2003-02-18 Access Pharmaceuticals, Inc. Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
US6589549B2 (en) 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
FR2809112B1 (fr) * 2000-05-16 2004-05-07 Centre Nat Rech Scient Materiaux a base de polymeres biodegradables et son procede de preparation
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
US7666445B2 (en) 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
IL155691A0 (en) * 2000-11-09 2003-11-23 Astrazeneca Ab Oral pharmaceutical composition containing a block copolymer
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
EP1408876A4 (de) 2001-06-22 2004-09-22 Durect Corp Koaxiale implantate nullter ordnung mit verlängerter freisetzung
CN1194688C (zh) * 2001-07-03 2005-03-30 山东绿叶制药股份有限公司 石杉碱甲及其衍生物或其盐的注射用缓释微球及其制备方法
US8778322B2 (en) * 2001-10-18 2014-07-15 Samyang Biopharmaceuticals Corporation pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery
WO2003092468A2 (en) * 2002-04-29 2003-11-13 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
US8465537B2 (en) * 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
CA2532837A1 (en) * 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical particles by controlled phase separation
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20050048127A1 (en) * 2003-07-22 2005-03-03 Larry Brown Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
CA2537315C (en) 2003-08-26 2015-12-08 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
US9066912B2 (en) * 2003-11-17 2015-06-30 Ethicon, Inc. Drug-enhanced adhesion prevention
CA2548822C (en) * 2003-12-08 2015-08-11 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
CA2553254C (en) * 2004-01-12 2013-12-17 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
US8277831B2 (en) * 2004-02-17 2012-10-02 Advanced Technologies And Regenerative Medicine, Llc. Drug-enhanced adhesion prevention
DK2074989T3 (da) 2004-02-23 2014-02-03 Euro Celtique Sa Misbrugssikker transdermal opioid-afgivelsesanordning
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
MXPA06012989A (es) * 2004-05-12 2007-06-12 Baxter Int Microesferas de acidos nucleicos, produccion y suministro de las mismas.
ATE409025T1 (de) * 2004-05-12 2008-10-15 Baxter Int Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
CA2566075A1 (en) * 2004-05-12 2005-12-01 Baxter Healthcare S.A. Microspheres comprising protein and showing injectability at high concentrations of said agent
US8980300B2 (en) 2004-08-05 2015-03-17 Advanced Cardiovascular Systems, Inc. Plasticizers for coating compositions
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
US20080095822A1 (en) * 2004-11-16 2008-04-24 Universite De Liege Active Substance Delivery System Comprising A Hydrogel Atrix And Microcarriers
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
EP1885335A1 (de) * 2005-04-27 2008-02-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) Oberflächenmodifizierte mikroteilchen und verfahren zu ihrer bildung und verwendung
JP2009507845A (ja) * 2005-09-07 2009-02-26 サウスウエスト リサーチ インスティテュート 改良された放出速度を示す生分解性微粒子薬学的処方物
US7758778B2 (en) 2005-09-07 2010-07-20 Southwest Research Institute Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents
US7261529B2 (en) * 2005-09-07 2007-08-28 Southwest Research Institute Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
US9693967B2 (en) * 2005-09-07 2017-07-04 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
JP5554496B2 (ja) * 2005-09-19 2014-07-23 ニューロナセント インコーポレイテッド 神経発生を刺激するための、およびニューロン変性を阻害するための方法および組成物
US7669732B2 (en) * 2005-10-25 2010-03-02 Imi Cornelius Inc. Cup lid dispenser
DE102006040123A1 (de) * 2006-08-26 2008-03-20 Evonik Degussa Gmbh Verfahren zur Herstellung von Mikropartikeln
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
US9028859B2 (en) * 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
EP3009477B1 (de) 2006-07-20 2024-01-24 Orbusneich Medical Pte. Ltd Bioresorbierbare polymerzusammensetzung für eine medizinische vorrichtung
EP2647712A3 (de) 2006-08-04 2013-11-20 Baxter International Inc Zusammensetzung auf Mikrokügelchenbasis zur Vorbeugung und/oder Umkehrung einer Neuerkrankung an autoimmun bedingter Diabetes
AU2007319577A1 (en) * 2006-10-06 2008-05-22 Baxter Healthcare S.A. Microencapsules containing surface-modified microparticles and methods of forming and using the same
EP2073754A4 (de) 2006-10-20 2012-09-26 Orbusneich Medical Inc Bioresorbierbare polymerzusammensetzung und hintergrund für eine medizinische vorrichtung
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
CN103933555B (zh) 2007-02-20 2018-06-01 阿普塔利斯制药有限公司 稳定的消化酶组合物
AU2008242842B2 (en) * 2007-04-17 2014-06-05 Baxter Healthcare Sa Nucleic acid microparticles for pulmonary delivery
AU2008265600B2 (en) 2007-06-21 2013-10-31 Neuronascent, Inc. Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
AU2008345047A1 (en) * 2007-12-26 2009-07-09 Gel-Del Technologies, Inc. Biocompatible protein particles, particle devices and methods thereof
US20090202642A1 (en) * 2008-02-08 2009-08-13 Xiao Huang Drug Delivery System Comprising Microparticles and Gelation System
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
GB0810990D0 (en) 2008-06-16 2008-07-23 Q Chip Ltd Device and method of making solid beads
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100050462A1 (en) * 2008-08-29 2010-03-04 Joseph Francis Attonito Body exsiccation chamber
WO2010057177A2 (en) 2008-11-17 2010-05-20 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
US20130268062A1 (en) 2012-04-05 2013-10-10 Zeus Industrial Products, Inc. Composite prosthetic devices
US8178030B2 (en) 2009-01-16 2012-05-15 Zeus Industrial Products, Inc. Electrospinning of PTFE with high viscosity materials
US9023896B2 (en) 2009-05-04 2015-05-05 Psivida Us, Inc. Porous silicon drug-eluting particles
JP2013501539A (ja) 2009-08-07 2013-01-17 ゼウス インダストリアル プロダクツ インコーポレイテッド 静電紡糸繊維層を備える補綴具及びその製造方法
WO2011151832A1 (en) 2010-06-03 2011-12-08 Ramot At Tel-Aviv University Ltd. Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
AR093181A1 (es) 2010-10-01 2015-05-27 Aptalis Pharmatech Inc Formulacion con contenido de enzimas digestivas bajo estable
EP2563956A4 (de) 2010-10-14 2013-09-18 Zeus Ind Products Inc Antimikrobielles substrat
WO2012061377A1 (en) 2010-11-01 2012-05-10 Psivida Us, Inc. Bioerodible silicon-based devices for delivery of therapeutic agents
US8524264B2 (en) 2010-12-07 2013-09-03 Kimberly-Clark Worldwide, Inc. Protein stabilized antimicrobial composition formed by melt processing
US8445032B2 (en) 2010-12-07 2013-05-21 Kimberly-Clark Worldwide, Inc. Melt-blended protein composition
US9648874B2 (en) 2010-12-07 2017-05-16 Kimberly-Clark Worldwide, Inc. Natural, multiple use and re-use, user saturated wipes
US9149045B2 (en) 2010-12-07 2015-10-06 Kimberly-Clark Worldwide, Inc. Wipe coated with a botanical emulsion having antimicrobial properties
US9832993B2 (en) 2010-12-07 2017-12-05 Kimberly-Clark Worldwide, Inc. Melt processed antimicrobial composition
US10821085B2 (en) 2010-12-07 2020-11-03 Kimberly-Clark Worldwide, Inc. Wipe coated with a botanical composition having antimicrobial properties
JP6203639B2 (ja) 2011-01-28 2017-09-27 メリット・メディカル・システムズ・インコーポレイテッドＭｅｒｉｔ Ｍｅｄｉｃａｌ Ｓｙｓｔｅｍｓ，Ｉｎｃ． 電界紡糸されたｐｔｆｅでコーティングされたステントおよび使用方法
ES2558756T3 (es) 2011-08-08 2016-02-08 Aptalis Pharma Limited Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
US8574628B2 (en) 2011-12-19 2013-11-05 Kimberly-Clark Worldwide, Inc. Natural, multiple release and re-use compositions
CN104114201A (zh) 2012-01-16 2014-10-22 美国医疗设备有限公司 被旋转纺丝材料覆盖的医疗器械和制造方法
US10507268B2 (en) 2012-09-19 2019-12-17 Merit Medical Systems, Inc. Electrospun material covered medical appliances and methods of manufacture
US9198999B2 (en) 2012-09-21 2015-12-01 Merit Medical Systems, Inc. Drug-eluting rotational spun coatings and methods of use
EP3988278A1 (de) 2013-03-13 2022-04-27 Merit Medical Systems, Inc. Seriell aufgetragene fasermaterialien sowie zugehörige vorrichtungen und verfahren
US9827703B2 (en) 2013-03-13 2017-11-28 Merit Medical Systems, Inc. Methods, systems, and apparatuses for manufacturing rotational spun appliances
BR112015021000A2 (pt) * 2013-03-14 2017-07-18 Allergan Inc composição de uma distribuição liberação prolongada e método de estabilizar proteínas durante o processo de fabricação
EP2968571A4 (de) 2013-03-15 2016-09-07 Psivida Inc Biologisch abbaubare zusammensetzungen auf siliciumbasis zur abgabe therapeutischer mittel
RU2679832C2 (ru) 2013-08-09 2019-02-13 Аллерган Фармасьютикалз Интернэйшнл Лимитед Композиция пищеварительных ферментов, подходящая для энтерального введения
JP6463366B2 (ja) 2013-10-10 2019-01-30 イースタン バージニア メディカル スクール １２−リポキシゲナーゼ阻害物質としての４−（（２−ヒドロキシ−３−メトキシベンジル）アミノ）ベンゼンスルホンアミド誘導体
CA2947998A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts
RU2019105756A (ru) * 2016-08-05 2020-09-08 ТАУРУС ДИВЕЛОПМЕНТ КОМПАНИ ЭлЭлСи Стабильный при комнатной температуре пероральный состав кальцитонина
US9987369B2 (en) 2016-11-01 2018-06-05 International Business Machines Corporation Vitamin functionalized gel-forming block copolymers for biomedical applications
US11534375B2 (en) * 2017-03-28 2022-12-27 Agency For Science, Technology And Research Solvent-free method of encapsulating a hydrophobic active
KR101969723B1 (ko) * 2017-10-26 2019-04-17 충남대학교산학협력단 용융 전기분사 공정에 의한 생분해성 마이크로비드의 제조방법
CN111206081B (zh) * 2018-11-21 2023-06-30 思纳福(苏州)生命科技有限公司 核酸检测微球、制备方法、试剂盒及高通量核酸检测方法
BR112021006406A2 (pt) * 2018-10-02 2021-07-06 Innocore Tech Holding B V forma de dosagem de gonadotrofina coriônica humana (hcg) de liberação prolongada
KR102419953B1 (ko) * 2018-12-20 2022-07-13 주식회사 엘지화학 폴리알킬렌카보네이트-폴리락트산 복합체, 이의 제조방법 및 이를 이용하여 제조된 성형품
CN113651950B (zh) * 2021-08-23 2023-12-22 陈强 一种可生物降解高分子微球及其制备方法
WO2023056368A1 (en) 2021-09-30 2023-04-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
CN116262157A (zh) * 2022-12-29 2023-06-16 高颜苑科技(深圳)有限责任公司 一种基于生发的多肽缓释微针制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092918B1 (de) * 1982-04-22 1988-10-19 Imperial Chemical Industries Plc Mittel mit verzögerter Freigabe
US4438253A (en) * 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
DE3786309T2 (de) * 1986-09-05 1994-02-10 American Cyanamid Co Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme.
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
JPH064540B2 (ja) * 1988-09-14 1994-01-19 多木化学株式会社 医用組成物
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5418010A (en) * 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
US5330768A (en) * 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters

Also Published As

Publication number Publication date
KR19990067014A (ko) 1999-08-16
WO1997015389A1 (en) 1997-05-01
EP0857081B1 (de) 2004-01-07
US5665428A (en) 1997-09-09
JPH11515016A (ja) 1999-12-21
EP0857081A1 (de) 1998-08-12
ATE257407T1 (de) 2004-01-15
KR100422391B1 (ko) 2004-06-12
CA2235602A1 (en) 1997-05-01
AU7479796A (en) 1997-05-15
EP0857081A4 (de) 1999-03-17

Similar Documents

Publication Publication Date Title
DE69631290D1 (de) Herstellung von peptidhältigen, biologisch abbaubaren mikrokügelchen durch ein schmelzverfahren
Orive et al. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates
KR920003962A (ko) 서방형 제제 및 그의 제조 방법
AU655935B2 (en) Pharmaceutical composition of florfenicol
JPH05103838A (ja) タンパク質又はポリペプチドと疎水性生物分解性ポリマーとの相互作用を包含する薬物投与システム
ES2112253T3 (es) Composiciones de farmaco de pequeña particula.
DE69428040D1 (de) Orale darreichungsform
AR002354A1 (es) Composiciones transdermicas que contienen farmacos de bajo peso molecular que son liquidos a las temperaturas ambientales.
DE69814885D1 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
KR910007508A (ko) 서방출 드레싱용 제제 및 이의 용도
ES2119743T3 (es) Conjugados de colageno y polimero.
ATE109000T1 (de) System zur freisetzung von medikamenten und dessen herstellungsmethode.
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DK561588A (da) Implanterbart biologisk nedbrydeligt system til frigivelse af biologisk virksomme stoffer
EP2258407A3 (de) Transdermale Mittel, die bei Raumtemperatur flüssige niedermolekulare Arzneistoffe enthalten
KR910007518A (ko) 서방성 제제
DK233080A (da) Overtraeksmiddel til foedevarer og medicinalvarer fremgangsmaade til fremstilling deraf samt produkter forsynet med et saadant overtraek
Lin et al. A novel fabrication of poly (ε-caprolactone) microspheres from blends of poly (ε-caprolactone) and poly (ethylene glycol) s
ES2067150T3 (es) Sistema de suministro de drogas bioelastomericas.
HUP0004405A2 (hu) Polietilénglikol mátrixszemcsék zsíros, olajos vagy ragacsos gyógyszerhatóanyagokhoz
EP0975334A1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
DE69837997D1 (de) Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels
RU99107658A (ru) Применение белков в качестве агентов против аутоиммунных заболеваний
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
JPH08225454A (ja) マイクロスフェア製剤

Legal Events

Date Code Title Description
8332 No legal effect for de